Nektar Therapeutics Reports Fourth Quarter and Year-End 2023 Financial Results
Go back to Nektar Therapeutics Reports Fourth Quarter and Year-End 2023 Financial Results| Nektar Therapeutics (NASDAQ: NKTR) | Delayed: 60.40 +3.34 (5.85%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $57.06 | 52 Week High | $19.98 | |||
| Open | $57.00 | 52 Week Low | $10.52 | |||
| Day High | $61.40 | P/E | N/A | |||
| Day Low | $56.40 | EPS | $-1.45 | |||
| Volume | 1,376,139 | |||||
